ARTICLE | Clinical News
IV CR845: Phase II data
July 27, 2015 7:00 AM UTC
Top-line data from a double-blind, U.S. Phase II trial in 65 hemodialysis patients with moderate to severe uremic pruritus showed that IV CR845 met the primary endpoint of reducing average worst itchi...